Term
Type I Hypersensitivity Actions |
|
Definition
Immune mediated- Th2 cells induce B cells to produce IgE antibodies which when restimulated by antigen leads to degranulization of mast cells |
|
|
Term
|
Definition
Edema in larynx, hypotension, airway obstruction, vascular dilation- Type I |
|
|
Term
|
Definition
Increase peristalsis- Type I |
|
|
Term
|
Definition
Broncho constriction and mucous secretion- Type I |
|
|
Term
|
Definition
increased mucus secretion (IL-13) |
|
|
Term
|
Definition
Stimulate B-Cell switch to IgE plasma cells |
|
|
Term
|
Definition
released from mast and Th2 cells and activates eosinophils |
|
|
Term
Type 2 Hypersensitivity Action |
|
Definition
Anti-body mediated reaction- IgG and IgM antibodies against tissues bind neutrophils and macrophages to activate complement system and leads to destruction of tissue |
|
|
Term
|
Definition
Type II against Rh blood group |
|
|
Term
AI Thrombocytopenic Purpura |
|
Definition
Type II against platelet GpIIB-IIIA---> bleeding |
|
|
Term
|
Definition
Type II against epidermal cell proteins---> bullae |
|
|
Term
|
Definition
Type II against basement membrane of glomerulu and lung alveolar |
|
|
Term
|
Definition
Type II- streptococcal cell wall antigen cross reacts with heart |
|
|
Term
|
Definition
Type II AI against nicotinic ACH receptors |
|
|
Term
|
Definition
Type II against TSH receptors leading to hyperthyroidism |
|
|
Term
|
Definition
Type II AI against gastric parietal cells and loss of intrinsic factor |
|
|
Term
Type III hypersensitivity actions |
|
Definition
Immune complex deposits in blood vessels mainly, activates complement and phagocytosis |
|
|
Term
|
Definition
Type III- vasculitis, arthrisis, nephritis |
|
|
Term
Poststreptococcal glomerunephritis |
|
Definition
Type III causing nephritis |
|
|
Term
|
Definition
Type III against Hep. B antigent leading to vasculitis |
|
|
Term
|
Definition
Type III- protein antigens given from a serum of another person leads to vasculitis, nephritis, and arthritis.
TX for snake bites and rabies expose |
|
|
Term
|
Definition
Type III- proteins injected into the subcuatneous skin leading to vasculitis of the skin |
|
|
Term
Treatments for Type II and III |
|
Definition
Plasmapheresis, antibody against CD20 found on B cells |
|
|
Term
|
Definition
CD4 and CD8 T cells activated by antigens, more organ specific than systemic |
|
|
Term
|
Definition
Inflammation due to cytokine release |
|
|
Term
|
Definition
cell lysis and tissue injur |
|
|
Term
|
Definition
activates macrophages and is released due to Th1 |
|
|
Term
|
Definition
Recruits leukocytes and neutrophils |
|
|
Term
|
Definition
Type IV with impared glucose metabolism |
|
|
Term
|
Definition
Type IV due to PTPN22/HLA-DR4 |
|
|
Term
|
Definition
Type IV against myelin CD25 genes |
|
|
Term
|
Definition
Type IV against intestinal microbes- NOD2 gene |
|
|
Term
|
Definition
|
|
Term
|
Definition
Type IV granulomatous inflammation |
|
|
Term
|
Definition
Type IV against viral proteins with hepatocyte death |
|
|
Term
|
Definition
Type IV overactivation of T cells of different specificities leading to shock and fever |
|
|
Term
Tx inflammation of type IV |
|
Definition
|
|
Term
|
Definition
|
|
Term
Tx for IV that inhibits T cell response |
|
Definition
|
|